ArticleFrontiers in endocrinology2025
Nonlinear association between gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio and risk of progression from normoglycemia to prediabetes: a 5-year cohort study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Current research on the association between the Gamma-glutamyl transferase to high-density lipoprotein ratio (GHR) and the risk of prediabetes (pre-DM) remains scarce. This study aims to explore the potential link between GHR and the risk of progression from normoglycemia to pre-DM. Methods: This retrospective cohort study included 8,168 individuals who voluntarily underwent health examinations at Shenzhen Dapeng New District Kuichong People's Hospital between January 2018 and December 2023. To assess the association between GHR and the risk of developing pre-DM, Cox proportional hazards regression models were employed. Cox proportional hazards regression model with cubic spline function was further utilized to investigate potential nonlinear association. Moreover, a competing risk Cox proportional hazards model was applied to account for the progression from normoglycemia to diabetes (DM) as a competing event in the progression from normoglycemia to pre-DM. Subgroup analyses and multiple sensitivity analyses were also performed to ensure the robustness of the findings. Results: Following multivariate adjustment, elevated GHR demonstrated a significant correlation with increased risk of progression from normoglycemia to pre-DM, showing a hazard ratio(HR) of 1.061 (95% CI: 1.028-1.095) for each 5-unit increment. A nonlinear relationship between them was identified, with an inflection point at a GHR value of 24.37. On the left side of the inflection point, the HR for the association between GHR (per 5-unit increase) and pre-DM risk was 1.394 (95% CI: 1.197, 1.623). Furthermore, the competing risk model revealed an HR of 1.05 (95% CI: 1.02, 1.09) for the association between GHR (per 5-unit increase) and pre-DM risk. Multiple sensitivity analyses confirmed the stability and reliability of these results. Conclusion: This study demonstrates that elevated GHR exhibits both a positive and nonlinear relationship with the risk of progression from normoglycemia to pre-DM among Chinese adults. Maintaining GHR values below the threshold of 24.37, coupled with further reduction efforts, may serve as an effective strategy to minimize pre-DM risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.